Skip to main content

Table 1 Patient characteristics

From: Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients

 

All patients

n = 144

Non-sepsis

n = 44

Sepsis

n = 100

p value

Sex (male/female)

88/56

27/17

61/39

ns

Age, years (mean ± SD)

58 ± 17.5

57.5 ± 20.1

58.3 ± 16

0.907

SAPS II, median (IQR)

47 (33–62)

44 (27–60)

48 (36–64)

0.176

SOFA, median (IQR)

8 (6–11)

6 (4–10)

8 (6–11)

0.008

Creatininemia, median (IQR), (μmol/L)

68 (27–102)

80 (29–107)

57 (26–101)

0.419

hsCRP, median (IQR), (mg/L)

108 (38–133)

31 (5–87)

180 (81–284)

<0.0001

PCT, median (IQR), (ng/mL)

1.89 (0.32–13.7)

0.3 (0.1–0.9)

4.7 (0.8–20.5)

<0.0001

Presepsin, median (IQR), (pg/mL)

1058 (510–2090)

454 (315–915)

1432 (773–2337)

<0.0001

ICU length of stay (IQR), (days)

4 (2–10)

3 (1–7)

5 (2–11)

0.04

ICU mortality, n (%)

34 (23.6)

9 (20.4)

25 (25)

ns

In-hospital mortality, n (%)

38 (26.3)

10 (22.7)

28 (28)

ns

  1. Comparison between septic and non-septic patients
  2. SAPS simplified acute physiology score, SOFA sequential organ failure assessment score, PCT procalcitonin, hsCRP high-sensitivity C-reactive protein
  3. p: differences between septic and non-septic patients